Youlisheng (Eltrombopag) 25mg Tablets | Qilu Generic TPO-R Agonist | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Youlisheng (China)

Generic name: eltrombopag olamine. Brand: Youlisheng (佑立升). Manufacturer: Qilu Pharmaceutical Co., Ltd. Origin: China-Mainland. Strength: 25 mg tablets, in 14-tablet and 28-tablet packs. Class: thrombopoietin receptor agonist.

Qilu's version adds a second domestic manufacturing source for eltrombopag in China, strengthening supply security and price competition for patients requiring long-term therapy.

What Is Youlisheng?

Youlisheng is an oral medicine that increases platelet production for adults and children aged 6 and over with chronic immune thrombocytopenia (ITP) who have responded poorly to steroids or immunoglobulins, and for severe aplastic anemia (SAA) patients with inadequate response to immunosuppression.

How Does Youlisheng Work?

It binds the c-Mpl (thrombopoietin) receptor on megakaryocyte precursors, activating JAK2/STAT signalling to drive platelet production. As a once-daily tablet it is far more convenient than injectable alternatives.

Indications

  • Chronic ITP (adults and children ≥6 years)
  • Severe aplastic anemia

Dosage

Adults with ITP typically take 50 mg once daily (two 25 mg tablets), titrated to maintain platelets ≥50 × 10⁹/L. East Asian and hepatically impaired patients start lower. Take fasting, separated from dairy and mineral supplements.

Side Effects

Common: headache, nausea, fatigue. Serious (rare): hepatotoxicity, thrombosis, cataract. Monitor liver function and platelets during treatment.

Storage

Keep at room temperature in a dry, light-protected place.

Why Choose the GLT?

Youlisheng offers Qilu's well-established manufacturing quality at a fraction of the originator price. With both 14- and 28-tablet packs, GLT can tailor supply to short titration courses or full monthly maintenance, all with complete CoA and CPP documentation.

How to Order

For a quotation on Youlisheng, contact GLT via WhatsApp +86 15234153837 or email [email protected].

FAQ

Who makes Youlisheng? Qilu Pharmaceutical Co., Ltd., a leading Chinese manufacturer whose eltrombopag generic passed consistency evaluation.

What pack sizes are available? 25 mg × 14 tablets and 25 mg × 28 tablets.

Is Youlisheng bioequivalent to Revolade? Yes, it passed NMPA bioequivalence evaluation against the originator.

How do I order from overseas? Contact GLT for China-sourced export with full documentation.

Related Oncology Products

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

Eltrombopag (Promacta) 25mg/50mg Tablets | US Originator TPO-R Agonist | GLT

Novartis originator Promacta (eltrombopag) 25mg & 50mg, 30 tablets

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Barinat (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Natco Pharma Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Natco Pharma Limited (India) — an affordable alternative to Olumiant...

SPINRAZA (Nusinersen) 12mg/5mL | Buy from China | SMA Therapy | GLT

Biogen's first-in-class antisense oligonucleotide for SMA, NMPA-approved and nationally reimbursed in China — buy from...